logo

For the Inventor, By the Inventor

Yokohama, Japan

Takahito Mukai

This inventor holds 5 USPTO granted patents and 3 EPO patents. Top assignee: Riken Corporation. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takahito Mukai. Retrieved from https://idiyas.com/inventor/takahito-mukai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Kanagawa, JP (2014)
  • Yokohama, JP (2012 - 2016)

Company Filing History:

goldMedal5 out of 890 
 
Riken Corporation
 patents

Years Active: 2012-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 9340790 - Method for constructing recombinant bacterium for producing non-native protein, and utilization of same (2016-05-17),
2. 8822180 - Method of synthesizing a suppressor tRNA, DNA construct and use thereof for producing a non-natural amino acid-incorporated protein (2014-09-02),
3. 8785152 - Process for production of non-natural protein having ester bond therein (2014-07-22),
4. 8293512 - Polypeptide having activity of aminoacyl-tRNA synthetase and use thereof (2012-10-23),
5. 8168407 - Method of synthesizing a suppressor TRNA, DNA construct and use thereof for producing a protein including a non-natural amino acid (2012-05-01),

Title: Takahito Mukai: Innovator in Recombinant Bacterium Technology

Introduction

Takahito Mukai is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing non-native proteins using recombinant bacteria. With a total of 5 patents to his name, Mukai's work is at the forefront of innovative scientific research.

Latest Patents

Mukai's latest patents include a groundbreaking method for constructing recombinant bacteria for producing non-native proteins. This method involves several key steps, such as expressing tRNA that recognizes the UAG codon and introducing a DNA construct into the bacterium to express specific gene functions. Another notable patent focuses on synthesizing a suppressor tRNA and a DNA construct that enables the production of proteins incorporating non-natural amino acids. These inventions highlight Mukai's expertise in genetic engineering and protein synthesis.

Career Highlights

Mukai is currently affiliated with Riken Corporation, a leading research institution in Japan. His work at Riken has allowed him to explore advanced biotechnological applications and contribute to the scientific community through his innovative research. His patents reflect a deep understanding of molecular biology and a commitment to pushing the boundaries of current scientific knowledge.

Collaborations

Mukai has collaborated with esteemed colleagues such as Shigeyuki Yokoyama and Kensaku Sakamoto. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research endeavors.

Conclusion

Takahito Mukai is a distinguished inventor whose work in recombinant bacterium technology is paving the way for advancements in biotechnology. His innovative patents and collaborations underscore his significant contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…